Xenetic Biosciences, Inc.XBIO決算レポート
Nasdaq · ヘルスケア · 医薬製剤
Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative long-acting biologic therapies for rare diseases, oncology, and autoimmune disorders. It uses its proprietary drug delivery platform to boost efficacy and cut dosing frequency, operating mainly across U.S. and European markets.
What changed in Xenetic Biosciences, Inc.'s 10-K — 2024 vs 2025
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.